KR102428253B1 - 신규한 다당류-단백질 접합체 및 이의 제조방법 - Google Patents

신규한 다당류-단백질 접합체 및 이의 제조방법 Download PDF

Info

Publication number
KR102428253B1
KR102428253B1 KR1020187027889A KR20187027889A KR102428253B1 KR 102428253 B1 KR102428253 B1 KR 102428253B1 KR 1020187027889 A KR1020187027889 A KR 1020187027889A KR 20187027889 A KR20187027889 A KR 20187027889A KR 102428253 B1 KR102428253 B1 KR 102428253B1
Authority
KR
South Korea
Prior art keywords
polysaccharide
conjugate
protein
activated
novel
Prior art date
Application number
KR1020187027889A
Other languages
English (en)
Korean (ko)
Other versions
KR20180121564A (ko
Inventor
라케쉬 라나
주니드 다랄
마노즈 쿠마르 치카라
다빈더 길
Original Assignee
엠에스디 웰컴 트러스트 힐레맨 랩스 피브이티. 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 엠에스디 웰컴 트러스트 힐레맨 랩스 피브이티. 리미티드 filed Critical 엠에스디 웰컴 트러스트 힐레맨 랩스 피브이티. 리미티드
Publication of KR20180121564A publication Critical patent/KR20180121564A/ko
Application granted granted Critical
Publication of KR102428253B1 publication Critical patent/KR102428253B1/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
KR1020187027889A 2016-03-15 2017-03-10 신규한 다당류-단백질 접합체 및 이의 제조방법 KR102428253B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201611008901 2016-03-15
IN201611008901 2016-03-15
PCT/IB2017/051408 WO2017158480A1 (fr) 2016-03-15 2017-03-10 Nouveaux conjugués polysaccharide-protéine et procédé pour les obtenir

Publications (2)

Publication Number Publication Date
KR20180121564A KR20180121564A (ko) 2018-11-07
KR102428253B1 true KR102428253B1 (ko) 2022-08-02

Family

ID=59851687

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187027889A KR102428253B1 (ko) 2016-03-15 2017-03-10 신규한 다당류-단백질 접합체 및 이의 제조방법

Country Status (9)

Country Link
JP (1) JP2019508468A (fr)
KR (1) KR102428253B1 (fr)
CN (1) CN108883192A (fr)
AU (1) AU2017234319B2 (fr)
BR (1) BR112018068523A2 (fr)
MX (1) MX2018010920A (fr)
RU (1) RU2758090C2 (fr)
WO (1) WO2017158480A1 (fr)
ZA (1) ZA201806043B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4309670A3 (fr) 2016-09-02 2024-07-17 Sanofi Pasteur, Inc. Vaccin contre neisseria meningitidis
SG11201911757WA (en) * 2017-06-27 2020-01-30 Msd Wellcome Trust Hilleman Laboratories Pvt Ltd Novel multivalent polysaccharide - protein conjugate vaccine composition and formulation thereof
CN110652585B (zh) * 2018-10-26 2023-05-26 武汉博沃生物科技有限公司 多糖-蛋白缀合物免疫制剂及其制备与应用
CN110302375A (zh) * 2019-06-27 2019-10-08 康希诺生物股份公司 一种糖缀合物及其用途
RU2770877C1 (ru) * 2021-04-08 2022-04-22 Федеральное бюджетное учреждение науки "Ростовский научно-исследовательский институт микробиологии и паразитологии" Способ получения антигенной конъюгированной субстанции гемофильного типа b микроба для создания вакцинных препаратов
CN114965784B (zh) * 2022-06-01 2023-10-27 艾美探索者生命科学研发有限公司 多糖活化度的测定方法
CN116087363A (zh) * 2023-02-15 2023-05-09 北京生物制品研究所有限责任公司 一种吸附型疫苗中羧甲基葡聚糖含量的检测方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030157129A1 (en) * 1995-06-23 2003-08-21 Smithkline Beecham Biologicals S.A. Vaccine comprising a polysaccharide antigen - carrier protein conjugate and free carrier protein
RU2233172C2 (ru) * 1997-07-17 2004-07-27 Бакстэ Хелскеа С.А. Иммуногенный коньюгат полисахарид h. influenzae - порин менингококка группы b (варианты), способ его получения, фармацевтическая композиция и способ индукции иммунного ответа у животного в отношении h.influenzae
GB0220198D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Modified saccharides,conjugates thereof and their manufacture
PT1896065E (pt) * 2005-06-27 2011-08-31 Glaxosmithkline Biolog Sa Processo para a preparação de vacinas
CN1709505B (zh) * 2005-07-13 2010-06-16 北京绿竹生物制药有限公司 多价细菌荚膜多糖-蛋白质结合物联合疫苗
EP3461496B1 (fr) * 2009-06-22 2023-08-23 Wyeth LLC Compositions et procédés d'élaboration de compositions immunogènes conjuguées à polysaccharides capsulaires de sérotypes 5 et 8 de staphylococcus aureus
CN104302315B (zh) * 2012-01-30 2018-02-06 印度血清研究所私人有限公司 免疫原性组合物及其制备方法
EP2870974A1 (fr) * 2013-11-08 2015-05-13 Novartis AG Vaccins conjugués de salmonelle

Also Published As

Publication number Publication date
CN108883192A (zh) 2018-11-23
RU2018135066A3 (fr) 2020-11-10
AU2017234319B2 (en) 2021-11-04
JP2019508468A (ja) 2019-03-28
AU2017234319A1 (en) 2018-09-27
WO2017158480A1 (fr) 2017-09-21
MX2018010920A (es) 2019-03-06
RU2758090C2 (ru) 2021-10-26
KR20180121564A (ko) 2018-11-07
BR112018068523A2 (pt) 2019-01-22
RU2018135066A (ru) 2020-04-06
ZA201806043B (en) 2019-05-29

Similar Documents

Publication Publication Date Title
KR102428253B1 (ko) 신규한 다당류-단백질 접합체 및 이의 제조방법
CN111093650B (zh) 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
CN111065387B (zh) 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
CN111093649B (zh) 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
JP5361767B2 (ja) 水中において改善された安定性を持つ修飾糖
JP2023036953A (ja) 肺炎連鎖球菌多糖－タンパク質コンジュゲートの免疫原性の増強
CN117736348A (zh) 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
EP2056871B1 (fr) Vaccins à base de matrice protéique et procédés de fabrication et d'administration de tels vaccins
JP6950099B2 (ja) 多価肺炎球菌多糖体−タンパク質複合体組成物
CN101583629B (zh) 修饰的糖类
ES2200067T3 (es) Fragmentos de polisacaridos antigenicos de tipo ii y tipo iii de streptococcus del grupo b, que tienen una estructura terminal 2,5-anhidro-d-manosa, y su vacuna conjugada.
KR101266552B1 (ko) 그룹 ｙ 수막염균에 대한 백신 및 그의 수막염균성 조합
JP2019526573A (ja) ナイセリア・メニンギティディスのワクチン
JP2019535775A (ja) 免疫原性コンジュゲート及びその使用
CN102089009A (zh) 偶联的Vi糖
JP2023537945A (ja) 出現血清型２４ｆを含む多価肺炎球菌複合糖質ワクチン
US20170198004A1 (en) Novel semi-synthetic meningococcal conjugate vaccine
US11246918B2 (en) Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant